WANBURY
Back to Cashflow Statement
|
WANBURY Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹26 Cr | ₹4.70 Cr | ₹20 Cr | ₹41 Cr | ₹17 Cr |
What is the latest Cash Flow from Operating Activities ratio of WANBURY ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹26 Cr |
| Mar2024 | ₹4.70 Cr |
| Mar2023 | ₹20 Cr |
| Mar2022 | ₹41 Cr |
| Mar2021 | ₹17 Cr |
How is Cash Flow from Operating Activities of WANBURY Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹26 Cr | 455.60 | |
| Mar2024 | ₹4.70 Cr | -76.27 | |
| Mar2023 | ₹20 Cr | -51.15 | |
| Mar2022 | ₹41 Cr | 142.91 | |
| Mar2021 | ₹17 Cr | - | |
Compare Cash Flow from Operating Activities of peers of WANBURY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WANBURY | ₹883.1 Cr | -2.8% | 13.7% | 2.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹437,663.0 Cr | 5.2% | 3.8% | -1.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹175,692.0 Cr | 2.2% | 11.3% | 7.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹143,909.0 Cr | 0.8% | 0.7% | 25.7% | Stock Analytics | |
| CIPLA | ₹107,827.0 Cr | 1.3% | 9.1% | -15.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,500.0 Cr | -3.5% | 2.7% | 10.3% | Stock Analytics | |
WANBURY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WANBURY | -2.8% |
13.7% |
2.5% |
| SENSEX | 0.8% |
5% |
-2.5% |
You may also like the below Video Courses